Klaus Sindahl
Investor Relations Contact presso HANSA BIOPHARMA AB
Profilo
Klaus Sindahl is currently the Head of Investor Relations at Hansa Biopharma AB since 2019.
Prior to this, he worked at Novozymes A for 12 years from 2006 to 2018 as an Investor Relations Officer.
Posizioni attive di Klaus Sindahl
| Società | Posizione | Inizio |
|---|---|---|
| HANSA BIOPHARMA AB | Investor Relations Contact | 29/04/2019 |
Precedenti posizioni note di Klaus Sindahl
| Società | Posizione | Fine |
|---|---|---|
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Public Communications Contact | 01/01/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Aziende private | 1 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
- Borsa valori
- Insiders
- Klaus Sindahl
